Digital Mindfulness-Based Treatment for Substance Use Disorder Recovery
NCT ID: NCT05852015
Last Updated: 2025-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2023-05-18
2025-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mindfulness Based Relapse Prevention: Efficacy and Mechanisms
NCT01159535
Mindfulness-Based Substance Use Prevention (MINDS-UP)
NCT06593470
Brief Interventions for Drop-out Re-engagement
NCT00350571
Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
NCT00032981
Targeting Self-regulatory Deficits Through Cognitive Remediation Intervention
NCT03373240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment-as-Usual (TAU)
TAU consists of weekly outpatient-based group therapy
Treatment-as-Usual (TAU)
TAU consists of weekly outpatient-based group therapy for substance use disorder
TAU Plus Digital Mindfulness-Based Treatment
TAU consists of weekly outpatient-based group therapy. The digital mindfulness-based treatment is multimedia app-based program teaching mindfulness skills.
Treatment-as-Usual (TAU)
TAU consists of weekly outpatient-based group therapy for substance use disorder
Digital Mindfulness Treatment
The digital mindfulness-based treatment is a multimedia app-based program teaching mindfulness skills to facilitate recovery from substance use disorder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatment-as-Usual (TAU)
TAU consists of weekly outpatient-based group therapy for substance use disorder
Digital Mindfulness Treatment
The digital mindfulness-based treatment is a multimedia app-based program teaching mindfulness skills to facilitate recovery from substance use disorder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluent in English and have a 6th grade or higher reading level
* Have completed 1 month or more of SUD treatment
* Report use of their primary substance of choice in past 6 months
* Are not currently enrolled in residential/inpatient treatment
* Are willing to be randomized
* Are willing and able to participate for the entire study period
* Are willing to provide locator information for follow-up
* Own a working, WIFI-enabled smartphone
Exclusion Criteria
* High suicide risk characterized by suicidal ideation with intent
* Homicidal ideation posing imminent danger to others
* Pending legal case, imminent incarceration, or a planned move that results in inability to commit to procedures during the entire study period
* Participation in the Phase 1 User Testing study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Complementary and Integrative Health (NCCIH)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Corey Roos
Assistant Professor of Psychiatry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
1 Church street
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000028537
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.